TY - JOUR
T1 - A comparative analysis of pharmacists' perspectives on codeine use and misuse - A three country survey
AU - Carney, Tara
AU - Wells, John
AU - Parry, Charles D.H.
AU - McGuinness, Padraig
AU - Harris, Richard
AU - Van Hout, Marie Claire
N1 - Funding Information:
This research project was reviewed by the South African Medical Research Council, Waterford Institute of Technology and Kings College London, and ethics approval was obtained. Proof of ethics approval can be provided upon request.
Funding Information:
The research leading to these results has received funding from the European Community’s Seventh Framework Programme FP7/2007–2013 under grant agreement no 611736.
Publisher Copyright:
© 2018 The Author(s).
PY - 2018/3/27
Y1 - 2018/3/27
N2 - Background: The misuse of codeine is of increasing concern in a number of countries, particularly as this relates to over -the-counter pain and cough relief medication, and is also supplied as a prescription medicine. The study aimed to obtain and analyse the opinions and experience of pharmacy staff with regard to codeine misuse. Methods: A cross-sectional web-based survey of pharmacy staff's perspectives on this issue was administered through professional or regulatory bodies and completed by samples drawn in South Africa (n=124), Ireland (n=464) and the United Kingdom (n=129). Results: The majority of participants reported combination codeine-containing products as most popular, but significantly more pharmacy staff in South Africa reported codeine-containing cough syrups as most commonly popular (X2=122.7(2), p<0.001). Codeine use was also seen significantly more of a public health problem in South Africa than in the other two countries (X2=7.6(2), p=0.02). There was no difference across countries in the level of codeine misuse reported by pharmacy staff. Further findings indicate that professional training and education is desired, with unequivocal findings for the need for greater codeine control (X2=12.0(2), p=0.002). Conclusion: In conclusion, there were some inter-country differences, but overall the findings seem to suggest that pharmacists across all three countries view codeine misuse as a problem among their customers. Recommendations centre on risk management, surveillance and staff training.
AB - Background: The misuse of codeine is of increasing concern in a number of countries, particularly as this relates to over -the-counter pain and cough relief medication, and is also supplied as a prescription medicine. The study aimed to obtain and analyse the opinions and experience of pharmacy staff with regard to codeine misuse. Methods: A cross-sectional web-based survey of pharmacy staff's perspectives on this issue was administered through professional or regulatory bodies and completed by samples drawn in South Africa (n=124), Ireland (n=464) and the United Kingdom (n=129). Results: The majority of participants reported combination codeine-containing products as most popular, but significantly more pharmacy staff in South Africa reported codeine-containing cough syrups as most commonly popular (X2=122.7(2), p<0.001). Codeine use was also seen significantly more of a public health problem in South Africa than in the other two countries (X2=7.6(2), p=0.02). There was no difference across countries in the level of codeine misuse reported by pharmacy staff. Further findings indicate that professional training and education is desired, with unequivocal findings for the need for greater codeine control (X2=12.0(2), p=0.002). Conclusion: In conclusion, there were some inter-country differences, but overall the findings seem to suggest that pharmacists across all three countries view codeine misuse as a problem among their customers. Recommendations centre on risk management, surveillance and staff training.
KW - Codeine
KW - Medications
KW - Opinions
KW - Pharmacy staff
UR - http://www.scopus.com/inward/record.url?scp=85044396833&partnerID=8YFLogxK
U2 - 10.1186/s13011-018-0149-2
DO - 10.1186/s13011-018-0149-2
M3 - Article
C2 - 29587814
AN - SCOPUS:85044396833
SN - 1747-597X
VL - 13
JO - Substance Abuse: Treatment, Prevention, and Policy
JF - Substance Abuse: Treatment, Prevention, and Policy
IS - 1
M1 - 12
ER -